COYA TAPIA to Survival Rate
This is a "connection" page, showing publications COYA TAPIA has written about Survival Rate.
Connection Strength
0.035
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.018
-
IMRT with ?8FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiat Oncol. 2014 Mar 25; 9:83.
Score: 0.012
-
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):178-83.
Score: 0.006